Etodolac Tablet, Extended Release
Product Images NDC 51672-4053

4 FDA label images from Tasun Pharmaceutical Industries, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 51672-4053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tasun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Etodolac 01)

Chemical Structure (Etodolac 01)
Chemical structure of etodolac, illustrating the molecular framework with aromatic and cycloalkane rings, and functional groups including a carboxylic acid and an amine substituent.*
FDA Label Image

Principal Display Panel (400 mg Bottle Label)

Principal Display Panel (400 mg Bottle Label)
Etodolac Extended-Release Tablets 400 mg label for a 60-tablet bottle by TaSun Pharmaceutical Industries, Inc. The label includes dosage form and strength, storage instructions, safety warnings, and distribution information by Taro Pharmaceuticals.*
FDA Label Image

Principal Display Panel (500 mg Bottle Label)

Principal Display Panel (500 mg Bottle Label)
Etodolac Extended-Release Tablets 500 mg oral tablet label by TaSun Pharmaceutical Industries, Inc. The label indicates a package size of 60 tablets and contains directions for storage, dispensing, and safety warnings. It emphasizes the 500 mg strength in an extended-release formulation and includes manufacturer and distributor information with a barcode.*
FDA Label Image

Principal Display Panel (600 mg Bottle Label)

Principal Display Panel (600 mg Bottle Label)
Label for Etodolac Extended-Release Tablets 600 mg, oral dosage form. The package contains 60 tablets. Label shows the drug name, strength (600 mg), and states it is an extended-release formulation. Additional directions for storage and dispensing are included. Manufacturer noted as Taro Pharmaceutical Industries Ltd., distributed by Taro Pharmaceuticals U.S.A., Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.